Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum-Reference-Cited by-同舟云学术

Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum

Published:2021-11-17 Issue: Volume: Page:
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Kozák Eszter¹^ORCID,Fülöp Krisztina¹^ORCID,Tőkési Natália¹^ORCID,Rao Nidhi¹^ORCID,Li Qiaoli²^ORCID,Terry Sharon F.³^ORCID,Uitto Jouni²^ORCID,Zhang Xiaoming⁴⁵,Becker Cyrus⁴⁵^ORCID,Váradi András¹,Pomozi Viola¹^ORCID

Affiliation:

1. Institute of Enzymology Research Centre for Natural Sciences Hungarian Academy of Sciences Centre of Excellence Budapest Hungary

2. Department of Dermatology and Cutaneous Biology PXE International Center of Excellence in Research and Clinical Care Sidney Kimmel Medicine CollegeJefferson Institute of Molecular MedicineThomas Jefferson University Philadelphia Pennsylvania USA

3. PXE International Washington District of Columbia USA

4. Theratrophix Sunnyvale California USA

5. Pyrogenyx Sunnyvale California USA

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14498

Reference35 articles.

1. ABCC6–Mediated ATP Secretion by the Liver Is the Main Source of the Mineralization Inhibitor Inorganic Pyrophosphate in the Systemic Circulation—Brief Report

2. Mutations in ABCC6 cause pseudoxanthoma elasticum